With intraperitoneal administration of EA 24 h pre-stroke, EA reduced the serum protein expressions of proinflammatory cytokines iNOS, IL-1, IL-6, and TNF-α in the cerebral global ischaemic stroke animal model [52]. The gene discussed is IL6; the disease is stroke disorder.